Clinical Trial Update: Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation [Phase 3]

View source ↗

Summary

Phase 3 trial of leronlimab in COVID-19 pneumonia patients requiring mechanical ventilation or ECMO is suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Leronlimab (leronlimab)

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: COVID-19 Pneumonia | Phase 3 | Status: SUSPENDED